The vagus nerve mediates the suppressing effects of peripherally administered oxytocin on methamphetamine self-administration and seeking in rats
The neuropeptide oxytocin has emerged as a promising pharmacotherapy for
methamphetamine (METH) addiction, and clinical trials of intranasal oxytocin are underway …
methamphetamine (METH) addiction, and clinical trials of intranasal oxytocin are underway …
Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats
There is emerging evidence that the neuropeptide oxytocin may be utilised as a treatment
for various psychopathologies, including drug addictions. Here we used an animal model to …
for various psychopathologies, including drug addictions. Here we used an animal model to …
Oxytocin acts in nucleus accumbens to attenuate methamphetamine seeking and demand
Background Evidence indicates that oxytocin, an endogenous peptide well known for its role
in social behaviors, childbirth, and lactation, is a promising addiction pharmacotherapy. We …
in social behaviors, childbirth, and lactation, is a promising addiction pharmacotherapy. We …
Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine‐seeking behaviour in rats
The psychostimulant methamphetamine (METH) is an addictive illicit drug. Systemic
administration of the neuropeptide oxytocin modulates METH‐related reward and METH …
administration of the neuropeptide oxytocin modulates METH‐related reward and METH …
The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement
The neuropeptide oxytocin has shown promise as an effective therapy in pre-clinical models
of methamphetamine (METH) addiction. The nucleus accumbens core (NAcc) has been …
of methamphetamine (METH) addiction. The nucleus accumbens core (NAcc) has been …
Chronic methamphetamine treatment induces oxytocin receptor up-regulation in the amygdala and hypothalamus via an adenosine A2A receptor-independent …
P Zanos, SR Wright, P Georgiou, JH Yoo… - Pharmacology …, 2014 - Elsevier
There is mounting evidence that the neuropeptide oxytocin is a possible candidate for the
treatment of drug addiction. Oxytocin was shown to reduce methamphetamine self …
treatment of drug addiction. Oxytocin was shown to reduce methamphetamine self …
Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in …
Recent preclinical evidence indicates that the neuropeptide oxytocin may have potential in
the treatment of drug dependence and drug withdrawal. Oxytocin reduces …
the treatment of drug dependence and drug withdrawal. Oxytocin reduces …
Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core
Addiction to the psychostimulant Methamphetamine (METH) is characterised by high rates of
relapse. Currently there are no approved effective pharmacotherapies for METH …
relapse. Currently there are no approved effective pharmacotherapies for METH …
Effects of oxytocin on methamphetamine-seeking exacerbated by predator odor pre-exposure in rats
CL Ferland, CM Reichel, JF McGinty - Psychopharmacology, 2016 - Springer
Rationale The endogenous oxytocin system has emerged as an inhibitor of drug-seeking
and stress in preclinical models. Objectives The goal of this study was to examine whether …
and stress in preclinical models. Objectives The goal of this study was to examine whether …
[HTML][HTML] The involvement of oxytocin in the subthalamic nucleus on relapse to methamphetamine-seeking behaviour
The psychostimulant methamphetamine (METH) is an addictive drug of abuse. The
neuropeptide oxytocin has been shown to modulate METH-related reward and METH …
neuropeptide oxytocin has been shown to modulate METH-related reward and METH …